Dec 17, 2025
Most Viewedlorundrostat, aprocitentan, baxdrostat
Three next‑generation antihypertensive agents are emerging as contenders for patients with hard‑to‑control blood pressure: lorundrostat and baxdrostat are selective aldosterone synthase inhibitors (AS...